⚠️ A rare and severe fungal sinus infection — seen almost exclusively in people with severely weakened immune systems
🧾 What is it?
Acute Invasive Aspergillus Sinusitis (AIAFS) is a rapidly progressing fungal infection of the sinuses, caused by Aspergillus species (typically A. fumigatus). It leads to tissue invasion, destruction, and potentially fatal complications if not treated urgently.
🛡️ Who is at Risk of Acute Invasive Aspergillus Sinusitis?
Acute Invasive Aspergillus Sinusitis (AIAFS) is very rare, and affects people who are significantly immunocompromised — meaning their immune systems are unable to control even common environmental fungi.
However, “immunocompromised” is not always black-and-white. There are different degrees of vulnerability, and it’s important to understand who is at greatest risk.
🔴 High-risk (severe immunosuppression)
These individuals are at the greatest risk for AIAFS:
-
Profound neutropenia (especially <500 neutrophils/μL for >10 days)
-
Acute leukaemia or stem cell transplantation
-
Solid organ transplant recipients on strong immunosuppressive regimens
-
High-dose corticosteroids (e.g. ≥20 mg prednisolone/day for ≥2 weeks)
-
Uncontrolled HIV/AIDS with low CD4 counts (<200)
-
Diabetic ketoacidosis or severe metabolic acidosis
🟠 Intermediate-risk (chronic or moderate immunosuppression)
Patients in this category may not be at risk of AIAFS, but may still be more vulnerable to chronic or allergic forms of aspergillosis or other infections:
-
Long-term oral corticosteroids at lower doses (e.g. <10 mg/day)
-
Biologic therapies for asthma (e.g. anti-IL-5, anti-IgE), which may subtly modulate immunity
-
Genetic susceptibility (e.g. subtle immune pathway deficiencies identified in CPA or ABPA)
-
COPD, bronchiectasis or severe asthma with impaired local defence
-
Malnutrition or poorly controlled diabetes
These patients are not typically at risk of invasive sinus aspergillosis, but may experience worsening of fungal conditions or atypical presentations of infection.
🟢 Low-risk (normal immune function)
People with normal immune function — even those with:
-
Allergic rhinitis
-
Chronic rhinosinusitis
-
Mild asthma or occasional infections
…are not at risk of developing AIAFS. Everyday exposure to Aspergillus spores is harmless to most people.
💬 Key Clarification:
Having aspergillosis does not automatically mean you are at risk of invasive sinus infection.
Many patients with CPA, ABPA, or SAFS are immunologically “fragile,” but not severely immunocompromised.
AIAFS typically only occurs in people with a combination of immune suppression and a very specific set of risks — especially when white blood cell function is severely impaired.
📋 Symptoms and Signs (typically <4 weeks onset)
-
Fever that does not respond to antibiotics
-
Facial pain or pressure, often severe and one-sided
-
Nasal congestion, discharge (often bloody or blackish)
-
Dark scabs (eschar) on the nasal mucosa or palate
-
Eye swelling, visual changes, or cranial nerve symptoms (if spread to the orbit or brain)
-
Altered mental state, seizures (in advanced cases)
🧪 Diagnosis
AIAFS is diagnosed based on:
-
Clinical suspicion in a high-risk patient
-
Endoscopic examination with biopsy and histology (showing hyphal invasion of tissue)
-
CT/MRI imaging to assess spread (bone, orbit, brain)
-
Culture and molecular testing of sinus material
-
Aspergillus PCR or galactomannan testing may help, but are not definitive alone
💊 Treatment Approach
Treatment must begin urgently, ideally within hours of suspicion.
1. Systemic antifungal therapy
-
First-line: Voriconazole or Isavuconazole
-
Alternatives: Liposomal Amphotericin B
-
Combination therapy may be considered in some cases
-
Therapeutic drug monitoring is essential (especially for voriconazole)
2. Surgical debridement
-
Prompt and aggressive endoscopic surgery is critical
-
Repeat procedures may be needed to remove necrotic tissue
3. Immunological support
-
Reversal of neutropenia if possible (e.g. G-CSF)
-
Reduction or withdrawal of immunosuppressive drugs
-
Management of underlying condition (e.g. glycaemic control in diabetes)
📈 Prognosis
-
Mortality is high (>50%) if not recognised and treated early
-
With rapid antifungal therapy and surgery, survival improves significantly
-
Regular monitoring, follow-up imaging, and immune recovery are crucial to long-term outcomes
🧠 Key Points to Remember
✅ This is a medical emergency, but
✅ It is extremely rare, and
✅ Almost exclusively affects those with profound immune suppression
✅ Not a risk to the general public or people with typical sinus infections
📣 Summary for Patient Awareness
Acute Invasive Aspergillus Sinusitis is very rare.
It is a fast-moving sinus infection caused by a fungus called Aspergillus, but it only happens in people with very weak immune systems, like those having chemotherapy or organ transplants.
It needs urgent treatment with antifungal medicine and sometimes surgery.
If your immune system is normal, this infection is not a risk to you.
Latest News posts
News archive